Evelyn Partners Investment Management Services Ltd Buys 3,110 Shares of CME Group Inc. $CME

Evelyn Partners Investment Management Services Ltd raised its holdings in CME Group Inc. (NASDAQ:CME) by 152.2% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 5,153 shares of the financial services provider’s stock after buying an additional 3,110 shares during the period. Evelyn Partners Investment Management Services Ltd’s holdings in CME Group were worth $1,447,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors and hedge funds have also bought and sold shares of the stock. Journey Strategic Wealth LLC raised its position in CME Group by 110.8% in the second quarter. Journey Strategic Wealth LLC now owns 3,869 shares of the financial services provider’s stock worth $1,066,000 after acquiring an additional 2,034 shares during the period. Varenne Capital Partners purchased a new stake in CME Group in the second quarter worth $23,717,000. Archer Investment Corp raised its stake in shares of CME Group by 3,596.2% in the second quarter. Archer Investment Corp now owns 961 shares of the financial services provider’s stock valued at $265,000 after buying an additional 935 shares during the period. Mediolanum International Funds Ltd lifted its position in shares of CME Group by 167.0% during the 2nd quarter. Mediolanum International Funds Ltd now owns 14,166 shares of the financial services provider’s stock valued at $3,892,000 after buying an additional 8,860 shares during the last quarter. Finally, Legal & General Group Plc raised its stake in CME Group by 10.8% in the 2nd quarter. Legal & General Group Plc now owns 2,312,251 shares of the financial services provider’s stock valued at $637,300,000 after acquiring an additional 225,449 shares during the period. 87.75% of the stock is owned by hedge funds and other institutional investors.

CME Group Stock Performance

CME opened at $273.09 on Friday. The company has a debt-to-equity ratio of 0.12, a quick ratio of 1.02 and a current ratio of 1.02. The stock has a market capitalization of $98.48 billion, a price-to-earnings ratio of 26.46, a PEG ratio of 4.41 and a beta of 0.38. The company has a fifty day moving average of $268.74 and a 200 day moving average of $272.78. CME Group Inc. has a fifty-two week low of $224.62 and a fifty-two week high of $290.79.

CME Group (NASDAQ:CME) last released its earnings results on Wednesday, October 22nd. The financial services provider reported $2.68 earnings per share for the quarter, beating the consensus estimate of $2.63 by $0.05. CME Group had a return on equity of 14.61% and a net margin of 58.84%.The firm had revenue of $1.54 billion for the quarter, compared to the consensus estimate of $1.56 billion. During the same quarter in the previous year, the company posted $2.68 EPS. The company’s revenue for the quarter was down 3.0% compared to the same quarter last year. As a group, sell-side analysts forecast that CME Group Inc. will post 10.49 earnings per share for the current fiscal year.

CME Group Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Tuesday, December 30th. Investors of record on Friday, December 12th will be issued a dividend of $1.25 per share. This represents a $5.00 annualized dividend and a yield of 1.8%. The ex-dividend date of this dividend is Friday, December 12th. CME Group’s dividend payout ratio (DPR) is 48.45%.

Insider Buying and Selling

In other CME Group news, Director Harold Eugene Jr. Ford sold 1,000 shares of the business’s stock in a transaction dated Monday, November 3rd. The shares were sold at an average price of $263.53, for a total transaction of $263,530.00. Following the sale, the director directly owned 1,091 shares in the company, valued at $287,511.23. This represents a 47.82% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, Director William R. Shepard acquired 262 shares of the business’s stock in a transaction dated Thursday, September 25th. The shares were bought at an average cost of $265.19 per share, for a total transaction of $69,479.78. Following the transaction, the director directly owned 258,459 shares of the company’s stock, valued at approximately $68,540,742.21. This trade represents a 0.10% increase in their position. Additional details regarding this purchase are available in the official SEC disclosure. Insiders sold 14,043 shares of company stock valued at $3,791,486 in the last 90 days. Corporate insiders own 0.30% of the company’s stock.

Analyst Ratings Changes

Several research firms have issued reports on CME. Raymond James Financial dropped their target price on CME Group from $309.00 to $307.00 and set an “outperform” rating on the stock in a research report on Monday, October 13th. UBS Group lowered their target price on shares of CME Group from $285.00 to $280.00 and set a “neutral” rating on the stock in a research note on Thursday, October 23rd. Morgan Stanley boosted their price target on shares of CME Group from $312.00 to $314.00 and gave the company an “overweight” rating in a research report on Thursday, October 23rd. JPMorgan Chase & Co. upped their price objective on shares of CME Group from $252.00 to $256.00 and gave the stock an “underweight” rating in a research report on Tuesday, October 14th. Finally, TD Cowen lifted their price objective on shares of CME Group from $288.00 to $290.00 and gave the stock a “hold” rating in a report on Thursday, October 23rd. Eight research analysts have rated the stock with a Buy rating, seven have given a Hold rating and three have given a Sell rating to the stock. Based on data from MarketBeat, the stock has a consensus rating of “Hold” and a consensus target price of $287.65.

CME Group Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.